Skip to main content
OpenTrials

Clinical trial condition

Breast Neoplasms

Explore clinical trials studying Breast Neoplasms. Study availability and eligibility vary by location and protocol.

609 public trials 216 recruiting studies
Refine in advanced search Browse all conditions

Breast Neoplasms trial results

Completed

Study of the Efficacy, Safety and Pharmacokinetics of Pamiparib (BGB-290) in Participants With Advanced Solid Tumors

NCT03333915

Conditions
Advanced High-grade Ovarian Cancer, Breast Diseases, Breast Neoplasms, +6 more
Locations
  • Cancer Hospital Chinese Academy of Medical Sciences Beijing, Beijing Municipality, China
  • Beijing Cancer Hospital Beijing, Beijing Municipality, China
  • Henan Cancer Hospital Zhengzhou, Henan, China
  • Hunan Cancer Hospital Changsha, Hunan, China
View Trial Details
Completed

CAB-ROR2-ADC Safety and Efficacy Study in Patients With TNBC or Head & Neck Cancer (Ph1) and NSCLC or Melanoma (Ph2)

NCT03504488

Conditions
Breast Diseases, Breast Neoplasms, Bronchial Neoplasms, +24 more
Locations
  • University of Arizona Cancer Center Tucson, Arizona, United States
  • City of Hope - Duarte Duarte, California, United States
  • University of California, San Diego (UCSD) - Moores Cancer Center La Jolla, California, United States
  • California Research Institute Los Angeles, California, United States
View all 59 locations
View Trial Details
Completed

Study to Assess Safety, Tolerability and Clinical Activity of BGB-290 in Combination With Temozolomide (TMZ) in Participants With Locally Advanced or Metastatic Solid Tumors

NCT03150810

Conditions
Adnexal Diseases, Breast Diseases, Breast Neoplasms, +39 more
Locations
  • Start Midwest Grand Rapids, Michigan, United States
  • Washington University in St Louis St Louis, Missouri, United States
  • Mount Sinai Prime New York, United States
  • Montefiore Medical Park At Eastchester Einstein Campus The Bronx, New York, United States
View all 22 locations
View Trial Details
Completed

Comparison of Biological Features Between pN0 Triple Negative Breast Tumours With Size < or = 10 mm (pT1a/b) Versus pT1c T2 < or = 30 mm

NCT02266420

Conditions
Breast Diseases, Breast Neoplasms, Neoplasms, +5 more
Locations
  • Institut de Cancerologie de L'Ouest - Site Paul Papin Angers, France
  • Centre Francois Baclesse Caen, France
  • Centre Jean Perrin Clermont-Ferrand, France
  • CH Emile ROUX Le Puy-en-Velay, France
View Trial Details
Completed

OXEL: Immune Checkpoint or Capecitabine or Combination Therapy as Adjuvant Therapy for TNBC With Residual Disease

NCT03487666

Conditions
Breast Diseases, Breast Neoplasms, Neoplasms, +5 more
Locations
  • MedStar Georgetown University Hospital Washington D.C., District of Columbia, United States
  • MedStar Washington Hospital Center Washington D.C., District of Columbia, United States
  • University of Chicago Chicago, Illinois, United States
  • John Theurer Cancer Center at Hackensack University Medical Center Hackensack, New Jersey, United States
View Trial Details
Completed

Galinpepimut-S in Combination With Pembrolizumab in Patients With Selected Advanced Cancers

NCT03761914

Conditions
Acute Myelogenous Leukemia, Adnexal Diseases, Breast Diseases, +45 more
Locations
  • St. Joseph Heritage Healthcare Santa Rosa, California, United States
  • Innovative Clinical Research Institute (ICRI) Whittier, California, United States
  • Miami Cancer Institute at Baptist Health, Inc. Miami, Florida, United States
  • Memorial Sloan Kettering Cancer Center Basking Ridge, New Jersey, United States
View Trial Details

Related conditions